Access cutting-edge plaque psoriasis treatment through this clinical trial at a research site in Hot Springs. Study-provided care at no cost to qualified participants.
Access plaque psoriasis specialists in Hot Springs at no cost
This study follows strict safety protocols and ethical guidelines
All study-related plaque psoriasis treatment provided free
The main aim of this study is to assess whether zasocitinib works better than deucravacitinib in treating participants with moderate-to-severe plaque psoriasis. Participants will take one tablet daily of either zasocitinib or a matching placebo, along with one capsule daily of either over-encapsulated deucravacitinib or a matching placebo, for a duration of 16 weeks. Participants will be in the study for up to 25 weeks, which includes screening period of up to 35 days, a 16-week treatment peri
Sponsor: Takeda
Check if you qualify for this plaque psoriasis clinical trial in Hot Springs, AR
If you're searching for plaque psoriasis treatment options in Hot Springs, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hot Springs research site is actively enrolling participants for this clinical trial. You'll receive care from experienced plaque psoriasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.